15 septiembre 2014
It has long been recognized that about four per cent of patients who are prescribed particular drugs for IBD go on to develop pancreatitis, an inflammation of the pancreas, which can be fatal. Now researchers have found that 17 percent of patients who have two copies of a particular genetic marker are likely to go on to develop pancreatitis if they are prescribed thiopurine drugs.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/qmegIynYBew/140915095859.htm
